1. Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer
   Bo-lin Liu et al, 2014, BMC Cancer CrossRef
2. Genome-Wide Analysis of lncRNA-mRNA Co-Expression Networks in CD133+/CD44+ Stem-like PDAC Cells
   Giasemi C. Eptaminitaki et al, 2023, Cancers CrossRef
3. The prognostic value and immunological role of CD44 in pan-cancer study
   Shaoyong Chen et al, 2023, Scientific Reports CrossRef
4. Synergistic Effects of Gold Nanocages in Hyperthermia and Radiotherapy Treatment
   Ai-wei Zhang et al, 2016, Nanoscale Research Letters CrossRef
5. Prognostic significance of tissue factor in patients with pancreatic cancer: a systematic review protocol
   Haiyuan Li et al, 2020, BMJ Open CrossRef
6. Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments
   Marzia Conte et al, 2022, Advanced Therapeutics CrossRef
7. Markers of pancreatic cancer stem cells and their clinical and therapeutic implications
   Arkadiusz Gzil et al, 2019, Molecular Biology Reports CrossRef
8. CD44v6 engages in colorectal cancer progression
   Lixin Ma et al, 2019, Cell Death & Disease CrossRef
9. Nonviral siRNA delivery systems for pancreatic cancer therapy
   Shahin Aghamiri et al, 2021, Biotechnology and Bioengineering CrossRef
10. Pancreatic cancer stem cell markers and exosomes - the incentive push
    Sarah Heiler et al, 2016, World Journal of Gastroenterology CrossRef
11. Chemokine (C-C motif) ligand 21/C-C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial-mesenchymal transition via the extracellular signal-regulated kinase signaling pathway
    Guangxin Zhong et al, 2017, Molecular Medicine Reports CrossRef
12. The clinical significance of CD44v6 in malignant and benign primary bone tumors
    Ameinh Hosseini et al, 2023, BMC Musculoskeletal Disorders CrossRef
13. High Dual Expression of the Biomarkers CD44v6/α2β1 and CD44v6/PD-L1 Indicate Early Recurrence after Colorectal Hepatic Metastasectomy
    Friederike Wrana et al, 2022, Cancers CrossRef
14. Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma
    ZHANXIONG XUE et al, 2016, Oncology Reports CrossRef
15. Morphological Heterogeneity in Pancreatic Cancer Reflects Structural and Functional Divergence
    Petra Sántha et al, 2021, Cancers CrossRef
16. Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models
    Qihong Zhao et al, 2016, Oncotarget CrossRef
17. Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis
    Garima Kaushik et al, 2021, Oncogene CrossRef
18. Expression and significance of CD44 and p-AKT in pancreatic head cancer
    Li Xiaoping et al, 2015, World Journal of Surgical Oncology CrossRef
19. Effect of CXCR4 and CD133 Co-expression on the Prognosis of Patients with Stage II~III Colon Cancer
    Xiao-Feng Li et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
20. Tissue factor potentiates adherence of breast cancer cells to human umbilical vein endothelial cells under static and flow conditions
    Yanling Jin et al, 2021, Cell Adhesion & Migration CrossRef
21. Cancer stem cell-derived exosome-induced metastatic cancer: An orchestra within the tumor microenvironment
    Khalid Rashid et al, 2023, Biochimie CrossRef
22. FXR induces SOCS3 and suppresses hepatocellular carcinoma
    Fei Guo et al, 2015, Oncotarget CrossRef
23. NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis
    Xiaoping Zhao et al, 2017, Scientific Reports CrossRef